These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17234723)

  • 1. Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant.
    Liu X; Schumacher FR; Plummer SJ; Jorgenson E; Casey G; Witte JS
    Carcinogenesis; 2007 Jun; 28(6):1232-6. PubMed ID: 17234723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dietary fatty acids and colorectal and prostate cancers: epidemiological studies].
    Astorg P
    Bull Cancer; 2005 Jul; 92(7):670-84. PubMed ID: 16123006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.
    Schuurman AG; van den Brandt PA; Dorant E; Brants HA; Goldbohm RA
    Cancer; 1999 Sep; 86(6):1019-27. PubMed ID: 10491529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma.
    Godley PA; Campbell MK; Gallagher P; Martinson FE; Mohler JL; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):889-95. PubMed ID: 8922296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
    Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
    Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fat and advanced prostate cancer.
    Bairati I; Meyer F; Fradet Y; Moore L
    J Urol; 1998 Apr; 159(4):1271-5. PubMed ID: 9507851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term intake of trans-fatty acids and risk of gallstone disease in men.
    Tsai CJ; Leitzmann MF; Willett WC; Giovannucci EL
    Arch Intern Med; 2005 May; 165(9):1011-5. PubMed ID: 15883239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-fatty acids and cancer: the evidence reviewed.
    Thompson AK; Shaw DI; Minihane AM; Williams CM
    Nutr Res Rev; 2008 Dec; 21(2):174-88. PubMed ID: 19087370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial.
    King IB; Kristal AR; Schaffer S; Thornquist M; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):988-92. PubMed ID: 15824175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.
    Chavarro JE; Stampfer MJ; Li H; Campos H; Kurth T; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1364-70. PubMed ID: 17585059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma.
    Freeman VL; Meydani M; Hur K; Flanigan RC
    Cancer; 2004 Dec; 101(12):2744-54. PubMed ID: 15495177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men.
    Kurahashi N; Inoue M; Iwasaki M; Sasazuki S; Tsugane AS;
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):930-7. PubMed ID: 18398033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium and fructose intake in relation to risk of prostate cancer.
    Giovannucci E; Rimm EB; Wolk A; Ascherio A; Stampfer MJ; Colditz GA; Willett WC
    Cancer Res; 1998 Feb; 58(3):442-7. PubMed ID: 9458087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha.
    Liu X; Plummer SJ; Nock NL; Casey G; Witte JS
    Am J Epidemiol; 2006 Nov; 164(10):984-9. PubMed ID: 16931544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
    Casey G; Neville PJ; Plummer SJ; Xiang Y; Krumroy LM; Klein EA; Catalona WJ; Nupponen N; Carpten JD; Trent JM; Silverman RH; Witte JS
    Nat Genet; 2002 Dec; 32(4):581-3. PubMed ID: 12415269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
    Stern MC; Siegmund KD; Corral R; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk.
    Kristal AR; Cohen JH; Qu P; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):719-25. PubMed ID: 12163324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of fatty acids with prostate cancer risk.
    Newcomer LM; King IB; Wicklund KG; Stanford JL
    Prostate; 2001 Jun; 47(4):262-8. PubMed ID: 11398173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.